Abstract
The preliminary results from our own (Goldstone et al. 1986; Gribben et al. 1987a;) and other centres (Appelbaum et al. 1985; Goldstone et al. 1987; Jagannath et al. 1987; Philip et al. 1986) prompted us to extend our ABMT trial in patients with Hodgkin’s disease. For the purposes of planning our own randomized studies we somewhat subjectively suggested that a reasonable starting point is a projected 5-year survival of less than 35%. Since the early morbidity and mortality of intensive therapy is high in this patient group, we further proposed that no patient should receive an ABMT if the projected survival is greater than 65% at 2 years. We have used the British National Lymphoma Investigation (BNLI) experience of over 600 patients with advanced HD treated by MOPP-type regimens as a data base for designing future studies (Gribben et al. 1987b).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Appelbaum FR, Sullivan KM, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Neiman PE, Sanders JE, Stewart P, Storb R (1985) Allogeneic marrow transplantation in the treatment of MOPP resistant Hodgkin’s disease. J Clin Oncol 3: 1490–1494
Goldstone AH, Anderson CC, Linch DC et al. (1986) High-dose therapy with autologous bone marrow transplantation for advanced relapsed adult Hodgkin’s disease. Bone Marrow Transplant 1: 297
Goldstone AH, Gribben JG, Dones L (1987) Fourth report of the ABMT experience of autologous bone marrow transplantation in lymphoma. Bone Marrow Transplant 2 [Suppl 1]: 200–203
Gribben J,Goldstone AH, Linch DL et al. (1987a) Autologous bone marrow transplantation in advanced relapsed adult Hodgkin’s disease. Bone Marrow Transplant 2 [Suppl 1]: 219
Gribben JG, Vaughan Hudson B, Linch DC (1987b) The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas. Hemat Oncol 5: 281–293
Gribben JG, Goldstone AH, Linch DC, Anderson CC, Richards JDM (1987c) Double auto-grafting as potential curative therapy for acute leukaemia. Bone Marrow Transplantation 2 [Suppl 1]: 46–48
Jagannath S, Armitage JO, Dicke KA et al. (1987) Autologous bone marrow transplantation (ABMT) for relapsed Hodgkin’s disease. Third International Conference on Malignant Lymphoma p 93 (Abstr 18)
Philip T, Dumont J, Teillet F, Maraninchi D et al. (1986) High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin’s disease. Br J Cancer 53: 737–742
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Gribben, J.G., Goldstone, A.H., Linch, D.C. (1989). Preliminary Results of Autologous Bone Marrow Transplantation in the Management of Resistant Hodgkin’s Disease: Experience of the Bloomsbury Transplant Group at University College, London. In: Diehl, V., Pfreundschuh, M., Loeffler, M. (eds) New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease. Recent Results in Cancer Research, vol 117. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83781-4_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-83781-4_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83783-8
Online ISBN: 978-3-642-83781-4
eBook Packages: Springer Book Archive